“…However, only very few drugs have been identified that block gap junction channels, and most of these are nonspecific, acting on other channel types. Among the classes of molecules that have been shown to reduce gap junction conductance are long-chain alcohols (Johnston et al, 1980;Burt and Spray, 1989); volatile anesthetics (Burt and Spray, 1989); glycyrrhetinic acid derivatives (Davidson and Baumgarten, 1988); oleamide (Guan et al, 1997); aminosulfonates (Bevans and Harris, 1999); tetraalkylammonium ions (Musa et al, 2001); arylaminobenzoates (Harks et al, 2001;Srinivas and Spray, 2003); polyamines (Musa and Veenstra, 2003); weak acids, which act by intracellular acidification (Spray et al, 1984); and certain antimalarial compounds, including quinine and derivatives such as mefloquine (Srinivas et al, 2001;Cruikshank et al, 2004). With the exception of intracellular acidification (where apparent pK a s for different connexins vary over a range of approximately 1 pH unit) (Stergiopoulos et al, 1999), polyamines (which blocks connexin (Cx) 40 but not Cx43 channels) (Musa and Veenstra, 2003), and quinine and its derivatives (which potently block Cx50 and Cx36 channels while sparing gap junctions formed of other connexins at even much higher concentrations; Srinivas et al, 2001;Cruikshank et al, 2004), uncoupling agents show poor selectivity for gap junctions formed by different types of connexins.…”